LivaNova PLC (NASDAQ:LIVN) Files An 8-K Other Events
Item 8.01 Other Events
had applied
|
i.
|
to the UK Financial Conduct Authority for the cancellation
of the standard listing of LivaNovas ordinary shares having a par value of 1 per share (ISIN: GB00BYMT0J19) (the Shares) on the Official List of the UK Listing Authority, and |
|
ii.
|
to the London Stock Exchange plc (the LSE) to cancel the
admission to trading of the Shares on the Main Market of the LSE (together, the Cancellation), with effect from and including April 5, 2017. |
8:00 a.m. British Summer Time today.
About LivaNova PLC (NASDAQ:LIVN)
LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing. The CRM business unit develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failure. CRM offers products, including leads and delivery systems, and information systems. The Neuromodulation business unit designs, develops and markets neuromodulation-based medical devices for the treatment of epilepsy and depression. Through the Neuromodulation business unit, the Company markets its implantable VNS Therapy systems that deliver vagus nerve stimulation therapy for the treatment of epilepsy and depression. LivaNova PLC (NASDAQ:LIVN) Recent Trading Information
LivaNova PLC (NASDAQ:LIVN) closed its last trading session up +0.15 at 50.65 with 521,444 shares trading hands.
